A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®

NCT00356421 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

58

Enrollment

INDUSTRY

Sponsor class

Stopped See termination reason in detailed description.

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Inhaled Human Insulin (Exubera®)
DRUG: Insulin lispro (Humalog)

Sponsor

Pfizer